Skip to main content
. 2019 Aug 14;18(4):2893–2900. doi: 10.3892/etm.2019.7898

Table VII.

Incidence of adverse reactions [n (%)].

Variable Low-dose group (n=44) Middle-dose group (n=42) High-dose group (n=39) χ2 value P-value
Dizziness 1 (2.27) 1 (2.38) 1 (2.56) 0.008 0.996
Sleepiness 0 (0.00) 1 (2.38) 2 (5.13) 2.321 0.313
Mild edema 0 (0.00) 0 (0.00) 3 (7.69)a,b 6.778 0.034
Stomach discomfort 1 (2.27) 2 (4.76) 1 (2.56) 0.504 0.777
Total adverse reactions 2 (4.55) 4 (9.52) 7 (17.95) 4.038 0.133
a

P<0.05 compared with the middle-dose group

b

P<0.05 the compared with low-dose group.